The observed increased PD-L1 expression on apoptotic melanoma and apoptotic glioblastoma cells after chemoradiation additionally calls for combination with agents targeting the PD-1/PD-L1 pathway to overcome the strong immune suppressive effects exerted by apoptotic cells per se. The gene discussed is CD274; the disease is glioblastoma.